Related Experiment Video
Updated: May 25, 2026

05:37
Single-Molecule Fluorescence Visualization of DNA Polymerase Dynamics at G-Quadruplexes
Published on: April 4, 2025
Structural basis for telomeric G-quadruplex targeting by naphthalene diimide ligands
Gavin W Collie1, Rossella Promontorio, Sonja M Hampel
1CRUK Biomolecular Structure Group, The School of Pharmacy, University of London, London, WC1N 1AX, United Kingdom.
Journal of the American Chemical Society
|January 28, 2012
Summary
Small molecules targeting human telomeric DNA G-quadruplexes offer a new cancer therapy. These compounds stabilize the G-quadruplex structure, inhibiting telomerase and cancer cell growth.
Area of Science:
- Biochemistry
- Structural Biology
- Medicinal Chemistry
Background:
- Human telomeres form G-quadruplex structures at their 3' end, inhibiting telomere maintenance by telomerase.
- Stabilizing these G-quadruplexes with small molecules is a therapeutic strategy against cancer.
- Developing selective ligands for parallel-stranded G-quadruplexes remains challenging due to limited structural data.
Purpose of the Study:
- To employ a structure-based approach for designing high-affinity and selective G-quadruplex-binding ligands.
- To investigate the structural basis for ligand interactions with the human telomeric G-quadruplex.
- To provide a rationale for the observed biological activity of G-quadruplex-targeting compounds.
Main Methods:
- Determined crystal structures of complexes between a human telomeric G-quadruplex and two naphthalene diimide ligands.
- Functionalized ligands with N-methyl-piperazine side-chains to promote parallel-stranded quadruplex topology.
- Analyzed ligand mobility and interactions within the G-quadruplex grooves.
Main Results:
- Two tetra-substituted naphthalene diimide compounds selectively bind to the 3' surface of parallel-stranded human telomeric G-quadruplexes.
- One ligand exhibited reduced mobility and enhanced G-quadruplex stabilization through electrostatic and hydrogen bonding interactions.
- Structural data correlate with biophysical, cellular, and in vivo anti-cancer activity.
Conclusions:
- Structure-based design can yield potent and selective G-quadruplex-binding ligands.
- Ligand-induced stabilization of telomeric G-quadruplexes offers a viable strategy for cancer therapy.
- Further development of small molecules targeting DNA G-quadruplexes holds promise for anti-cancer drug discovery.

